Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-23-017652
Filing Date
2023-02-09
Accepted
2023-02-09 17:01:28
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-4/A tm2229000-5_s4a.htm S-4/A 8728060
2 EXHIBIT 10.1 tm2229000d4_ex10-1.htm EX-10.1 125043
3 EXHIBIT 10.1(A) tm2229000d4_ex10-1a.htm EX-10.1(A) 7994
4 EXHIBIT 10.2 tm2229000d4_ex10-2.htm EX-10.2 93733
5 EXHIBIT 10.3 tm2229000d4_ex10-3.htm EX-10.3 165919
6 EXHIBIT 10.4 tm2229000d4_ex10-4.htm EX-10.4 88531
7 EXHIBIT 10.12 tm2229000d4_ex10-12.htm EX-10.12 37353
8 EXHIBIT 23.1 tm2229000d4_ex23-1.htm EX-23.1 2015
9 EXHIBIT 23.2 tm2229000d4_ex23-2.htm EX-23.2 2034
10 EX-FILING FEES tm2229000d4_ex-filingfees.htm EX-FILING FEES 29481
11 GRAPHIC tm2229000d1-fc_indic4clr.jpg GRAPHIC 227545
12 GRAPHIC tm2229000d4_ex10-2img001.jpg GRAPHIC 1135
13 GRAPHIC tm2229000d4_ex10-12img001.jpg GRAPHIC 4937
  Complete submission text file 0001104659-23-017652.txt   9594247
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-269006 | Film No.: 23607155
SIC: 2834 Pharmaceutical Preparations